Compare ECO & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | ECO | HTFL |
|---|---|---|
| Founded | 2018 | 2007 |
| Country | Greece | United States |
| Employees | N/A | 843 |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.5B |
| IPO Year | 2023 | N/A |
| Metric | ECO | HTFL |
|---|---|---|
| Price | $54.59 | $26.78 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $42.00 | $38.20 |
| AVG Volume (30 Days) | 467.3K | ★ 2.1M |
| Earning Date | 05-13-2026 | 05-14-2026 |
| Dividend Yield | ★ 6.12% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $16.07 | $27.66 |
| Revenue Next Year | N/A | $23.55 |
| P/E Ratio | $18.60 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $22.38 | $20.13 |
| 52 Week High | $58.45 | $41.22 |
| Indicator | ECO | HTFL |
|---|---|---|
| Relative Strength Index (RSI) | 56.56 | 39.35 |
| Support Level | $48.27 | $24.77 |
| Resistance Level | $57.47 | $32.69 |
| Average True Range (ATR) | 2.28 | 2.33 |
| MACD | 0.29 | -0.82 |
| Stochastic Oscillator | 74.55 | 8.73 |
Okeanis Eco Tankers Corp is an international owner and operator of a fleet of tanker vessels used for the transportation of crude oil. Its fleet consists of modern Suezmax and VLCC tankers that are designed in accordance with eco-efficiency standards, including features such as reduced fuel consumption, exhaust gas cleaning systems, and ballast water treatment systems. All of the company's revenue is derived from a single segment, the crude oil tanker segment. Geographically, the maximum revenue is generated from Europe, and the rest from Asia, North America, and South America.
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.